Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.67
Delayed Data
As of Dec 02
 +0.15 / +2.72%
Today’s Change
2.80
Today|||52-Week Range
7.80
+12.28%
Year-to-Date
3 Biotech Investing Tips That Could Earn You Thousands
Nov 28 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close5.52
Today’s open5.56
Day’s range5.50 - 5.78
Volume1,083,949
Average volume (3 months)1,761,883
Market cap$600.8M
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)-17.99%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book6.86

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...+0.31+0.99%
HRTXHeron Therapeutics I...+0.20+1.32%
CLLSCellectis SA+0.60+3.66%
PGNXProgenics Pharmaceut...-0.03-0.35%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs